{
}
Blue Trust Inc. now holds 1,718 shares of Chewy, valued at $58,000, after acquiring 320 additional shares. Institutional investors own 93.09% of Chewy, which has received a "Moderate Buy" rating from analysts, with Citigroup raising its price target to $42.00, suggesting a potential upside of 24.56%. Recent insider transactions include CEO Sumit Singh selling over 191,000 shares, while major shareholder Argos Holdings sold 7 million shares, totaling approximately $250 million.
Cerity Partners LLC increased its stake in Chewy by 42.4% in Q3, now holding 15,324 shares valued at $449,000. Bank of Montreal Can raised its stake by 261.2%, owning 158,166 shares worth $4.7 million, while FMR LLC boosted its holdings by 166.8% to 3.99 million shares valued at $117 million. Analysts have a consensus "Moderate Buy" rating for Chewy, with a target price raised to $40 by JPMorgan Chase & Co., indicating a potential upside of 20.49%.
Polar Asset Management Partners Inc. increased its stake in Chewy by 26.5%, owning 288,733 shares valued at $9.67 million. Barclays raised Chewy's target price from $40 to $44, indicating a potential upside of 34.22%. The stock has a "Moderate Buy" rating, with 93.09% of shares held by institutional investors.
On CNBC's "Halftime Report Final Trades," Joseph M. Terranova highlighted JPMorgan Chase ahead of its April 11 earnings call, expecting a rise in quarterly earnings to $4.57 per share. Brian Belski favored Chewy, which reported a strong fourth-quarter EPS of 28 cents, significantly above expectations. Karen Firestone noted Wabtec's leadership in railcar manufacturing, with earnings due April 23, while Jenny Van Leeuwen Harrington selected Crown Castle, which recently announced a CEO transition.
Deutsche Bank has raised its price target for Chewy, Inc. to $33 from $31 while maintaining a hold rating. Chewy is an e-commerce company specializing in pet products and services, offering a wide range of items including food, treats, healthcare products, and supplements for various pets. Customers can access these products through its website and mobile applications.
Morgan Stanley views Chewy (NYSE: CHWY) as a strong buying opportunity following a 15% stock pullback, maintaining an Overweight rating due to solid fundamentals despite elevated FY25 guidance concerns. The recent decline is attributed to broader market issues rather than company-specific problems, with analysts noting Chewy's high non-discretionary product mix and loyal customer base as factors that could lead to outperformance in a weakening consumer environment. They anticipate strong Q4 results, but caution that conservative guidance may lead to short-term stock pressure, presenting a potential buying opportunity.
Chewy, Inc. is a leading e-commerce platform focused on pet products and services, catering to a variety of animals including dogs, cats, and reptiles. The company offers a wide range of high-quality items, from pet food and treats to health products like vitamins and dental care. Customers can shop through its website and mobile applications.
S&P 500 futures rose as Alphabet's shares jumped 5% following strong earnings, exceeding expectations with $88.27 billion in revenue. The Nasdaq Composite hit a record high, driven by tech stocks, while investors await GDP growth data expected at 3.1% for Q3. Chipotle's mixed results led to a 3% dip in shares, and Chewy fell nearly 2% after meme stock leader Keith Gill dissolved his stake.
The global pet healthcare market is projected to grow from $239.29 billion in 2023 to $255.96 billion in 2024, with a CAGR of 7.0%. Key drivers include an increasing pet population, advancements in veterinary care, and a focus on preventive health. By 2028, the market is expected to reach $353.66 billion, driven by trends such as pet humanization and economic prosperity.
David Einhorn of Greenlight Capital believes Peloton's stock could rise to $31.50 per share if the company successfully implements cost-cutting measures, potentially doubling its adjusted EBITDA. Despite challenges, Peloton's high-margin subscription model and loyal customer base position it for recovery, with projected EBITDA of $400-$500 million if management aligns costs with industry benchmarks. Einhorn emphasizes the need for new leadership to achieve these goals.
Chewy, Inc.
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
chewy stock sees institutional investment growth and analyst upgrades
17:30 28.03.2025
institutional investors increase stakes in chewy amid positive analyst ratings
UBS Group AG
FMR LLC
Chewy, Inc.
JPMorgan Chase & Co.
Cerity Partners LLC
USA
Sumit Singh
Satish Ramanlal Mehta
Show more
15:34 28.03.2025
chewy stock sees increased institutional investment and positive analyst ratings
14:47 28.03.2025
final trades highlight jpmorgan chewy wabtec and crown castle updates
United States Dollar
Chewy, Inc.
Crown Castle Inc.
JPMorgan Chase & Co.
USA
Joseph M. Terranova
Karen Firestone
Brian Belski
Jenny Van Leeuwen
Show more
13:44 27.03.2025
deutsche bank increases chewy price target to thirty three dollars
12:15 19.03.2025
Morgan Stanley sees buying opportunity in Chewy after recent stock pullback
14:54 17.03.2025
chewy inc expands pet product offerings with diverse e commerce services
18:28 27.11.2024
s and p 500 futures rise as alphabet and tech earnings impress
United States Dollar
Reddit, Inc.
Amazon.com, Inc.
Apple Inc.
Snap Inc.
Advanced Micro Devices, Inc.
Visa Inc.
Chewy, Inc.
Alphabet Inc.
Chipotle Mexican Grill, Inc.
Meta Platforms, Inc.
Microsoft Corporation
USA
Rob Haworth
Keith Gill
Brendan McDermid
Alex Harring
Show more
23:05 29.10.2024
global pet healthcare market projected to reach 353 billion by 2028
Elanco Animal Health Incorporated
Norbrook Laboratories Ltd.
PETCO Animal Supplies Inc.
Phibro Animal Health Corporation
Royal Canin
Merck & Co., Inc.
VCA Animal Hospitals Inc.
IDEXX Laboratories, Inc.
Perrigo Company plc
Chewy, Inc.
Colgate-Palmolive Company
Mars Inc.
Trupanion, Inc.
Nestlé S.A.
Zoetis Inc.
Sanofi
Boehringer Ingelheim International GmbH
Vetoquinol S.A.
Ceva Sante Animale SA
General Mills, Inc.
USA
IND
AUS
FRA
DEU
BRA
IDN
JPN
RUS
GBR
KOR
CHN
Sanofi SA
Mars Inc.
General Mills Inc.
Nestle SA
Merck & Co Inc.
Show more
03:01 29.10.2024
peloton's potential turnaround hinges on new leadership and cost-cutting strategies
adidas AG
Netflix, Inc.
Peloton Interactive, Inc.
Planet Fitness, Inc.
Spotify AB
Chewy, Inc.
USA
Richard Buery
Karen Boone
David Einhorn
Bill Ackman
Show more
19:45 25.10.2024
Trending
Subcategory
Stock Market Updates
Corporate News
Industry Trends
Finance Mergers & Acquisitions
Banking Regulations
Global Financial Events
Market Analysis and Predictions
Retail and Consumer Goods
CEO Changes
Financial Scams and Security
Global Trade Developments
Central Bank Actions
GDP Growth & Recession Forecasts
Government Policies
Hedge Funds & Private Equity
Industry Mergers & Acquisitions
Inflation and Monetary Impact
Startups & Entrepreneurship
Workplace Trends
Government Economic Policies
Countries:
Companies:
The Goldman Sachs Group, Inc.
JPMorgan Chase & Co.
Tesla, Inc.
Apple Inc.
Bank of America Corporation
Wells Fargo & Company
Citigroup Inc.
Barclays PLC
Morgan Stanley
Deutsche Bank Money Market PP
Lloyds Banking Group plc
Huawei Technologies CO. Ltd.
American Express Company
Credit Suisse Strategic Income I
Berkshire Hathaway Inc.
UBS Group AG
AMERICAN EXPRESS
Northern Trust Corporation
Amazon.com, Inc.
Banco Santander, S.A.
Currencies:
United States Dollar
Euro
Chinese Yuan
Swiss Franc
British Pound Sterling
Indian Rupee
Japanese Yen
Canadian Dollar
Australian Dollar
Russian Ruble
Mexican Peso
Saudi Riyal
United Arab Emirates Dirham
Indonesian Rupiah
Hong Kong Dollar
Danish Krone
Offshore Chinese Yuan
Singapore Dollar
Ghanaian Cedi
South Korean Won
People: